Effects of simvastatin on bleomycin-induced pulmonary fibrosis in female rats

Tulek, Baykal; Kiyan, Esen; Kiyici, Aysel; Toy, Hatice; Bariskaner, Hulagu; Suerdem, Mecit.
Biol. Res ; 45(4): 345-350, 2012. ilus
Artículo en Inglés | LILACS | ID: lil-668684

Documentos relacionados

  1. Effects of simvastatin on bleomycin-induced pulmonary fibrosis in female rats.
  2. Sesamol attenuates bleomycin-induced pulmonary toxicity and fibrosis in experimental animals.
  3. Chlorogenic Acid Inhibited Epithelial-Mesenchymal Transition to Treat Pulmonary Fibrosis through Modulating Autophagy.
  4. 4-OI ameliorates bleomycin-induced pulmonary fibrosis by activating Nrf2 and suppressing macrophage-mediated epithelial-mesenchymal transition.
  5. Empagliflozin Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats by Modulating Sesn2/AMPK/Nrf2 Signaling and Targeting Ferroptosis and Autophagy.
  6. <i>Phœnix dactylifera,</i> L. seed oil alleviates Bleomycin-induced pulmonary fibrosis and oxidative stress in <i>Wistar</i> rats.
  7. Anti-Fibrotic and Anti-Inflammatory Role of NO-Sensitive Guanylyl Cyclase in Murine Lung.
  8. Industrial Elimination of Essential Oils from <i>Rosmarinus Officinalis</i>: In Support of the Synergic Antifibrotic Effect of Rosmarinic and Carnosic Acids in Bleomycin Model of Lung Fibrosis.
  9. Timosaponin BII inhibits TGF-ß mediated epithelial-mesenchymal transition through Smad-dependent pathway during pulmonary fibrosis.
  10. The novel peptide DR4penA attenuates the bleomycin- and paraquat-induced pulmonary fibrosis by suppressing the TGF-ß/Smad signaling pathway.